Ovarian Cancer
Reports summarize ovarian cancer research from Catholic University
Published in Drug Law Weekly, July 29th, 2008
"To our knowledge, very few data about the role of Topoisomerase II alpha (TOPO-II alpha), an enzyme involved in critical steps of tumour cell proliferation and chemoresistance are currently available in ovarian cancer patients. The aim of this study was to investigate the prognostic value of TOPO-II alpha expression in a large, single institution series of 96 primary untreated advanced ovarian cancer patients admitted to the Gynecologic Oncology Unit, Catholic University of Campobasso and Rome," scientists in Campobasso, Italy report.
"Immunohistochemistry was carried out by using the MoAb anti-human TOPO-II alpha antibody (clone Ki-SI). TOPO-II alpha immunoreaction...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2008-07-29)
More Articles from Drug Law Weekly
- Adverse Drug Reactions
Data on adverse drug reactions published by T.R. Deer and colleagues - Amgen
Amgen and Ortho Biotech Settle Antitrust Suit - APEX Analytix
APEX Analytix Grows Its Global Customer Base - AT&T Inc.
New Kentucky Law Helps Police Stem Metal Thefts - Biologics
Insmed Partners With Bill Thomas, Former House Ways and Means Chairman, as Strategic Advisor - Biotech Business
RNCOS Releases a New Report- Booming US Generic Drug Market - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
